Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
We compare which structure offers superior tax efficiency between dividend ETFs and taxable funds, focusing on after-tax returns and fees.
28,247 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
A confidential settlement in Maryland ends a high-profile dispute over HeLa cell patents and profits, signaling a new...
A top economist says wage gains aren’t keeping up with inflation, leaving Americans literally getting squeezed as hou...
AMD posts a 55% month gain as AI data center demand accelerates, eclipsing Intel’s advance. The move sparks a debate ...
As Micron Technology rides AI-driven memory demand, investors debate a bold forecast. Market models suggest a potenti...
AppLovin rode a massive multi-year rally, but a pivot to pure-play ad tech and a softening macro beat have investors ...
Oil prices surged after ships halted near Hormuz amid Iranian warnings, signaling a potential energy shock for househ...
A key chart pattern has flipped bullish for altcoins, with analysts arguing it mirrors setups that preceded massive r...
Retail investors are retreating from crypto while institutions step up exposure, reshaping liquidity and risk. The sh...
Stocks surged on unconfirmed chatter of an Apple chip deal with Intel, fueling bets on Intel’s foundry business. Anal...
SoftBank CEO Masayoshi Son says global AI demand will need roughly $5 trillion each year to scale infrastructure, arg...
Interactive Brokers clients favored Nvidia after its record quarter, purchasing the stock as it pulled back from the ...